CSL Ltd (ASX: CSL) shares closed around 1% higher on Thursday afternoon, at $125.53 a piece.

The increase continues the biotech company’s strong rally over the past month or so. 

The shares have now climbed around 26% over the past month, and have now rebounded 36% from a 10-year low in early June.

It’s good news for investors, but there is still some way to go before the stock recoups the huge losses it shed this year.

Even after the rebound, CSL shares are still down 27% for the year-to-date, and are 48% lower than 12 months ago.

Why are CSL shares finally rebounding?

It looks like investors have finally recognised that the ASX healthcare share reached a price point well below fair value.

After such a huge share price drop in early 2026, it looks like even nervous investors now consider that the bad news and earnings outlook downgrade is priced in. 

Momentum has picked up pace recently as bargain-hunting investors take advantage of opportunities in oversold stocks.

But can it keep going?

Can they keep climbing higher?

I think the latest increase shows that investors are now looking forward to whether management can improve operations, and if so, what CSL’s FY27 and FY28 earnings might look like.

I think there is a lot of potential too. After all, CSL is operating in a high-growth market, and its blood plasma division dominates the market for rare blood disorders and immunoglobulin products. 

Global demand for plasma therapies is strong and growing, too. There is recurring demand and limited competition, which makes CSL well-placed to carve out a significant portion of the market.

I think that once CSL is able to turn around its financials, investor confidence will follow.

Here’s what the experts tip for CSL shares

Market sentiment for CSL shares looks to have shifted slightly, and analysts are now divided about how much further they can climb.

Although they do agree there will be some element of upside ahead.

Market Index data shows most brokers (seven out of nine) have a hold rating on CSL shares. However, the $131.48 target price implies a potential 4% upside, at the time of writing.

TradingView data also shows that, of 18 analysts, 10 have a hold rating and another eight have a buy or strong buy rating on the stock. 

The average $140.15 target price implies a potential 11% upside at the time of writing. However, some analysts tip the ASX healthcare shares to fall around 17% to $104.55, while others forecast CSL shares to jump around 58% higher to $199.68, at the time of writing.

Morgans is one optimistic broker. It has a buy rating with a price target of $147.59.

The team at Macquarie is more cautious. The broker has a lower price target of $114 and a neutral stance. It cites uncertainty across CSL’s core plasma and albumin businesses, as well as ongoing competitive pressures.

The post Up 36%: Can CSL shares keep rebounding? appeared first on The Motley Fool Australia.

More reading

• 3 ASX blue-chip shares that could be strong long-term value plays
• Which ASX 200 sectors paid the highest dividend yields in FY26?
• Is CSL a fallen ASX giant to buy in July?
• The only 3 ASX blue-chip shares I’d buy and hold until 2036
• July is historically one of the best months for ASX shares. Can July FY27 deliver?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has recommended CSL and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Superannuation can be a powerful place to build passive income for retirement.

It gives investors a long time horizon, tax advantages, and the ability to keep compounding returns over many years.

But how much super would someone actually need to generate $52,000 per year in passive income?

Let’s break it down.

$52,000 per year in passive income

A passive income target of $52,000 per year works out to $1,000 a week or around $4,333 per month.

That could be a useful amount for many retirees. It could help cover everyday living costs, bills, insurance, travel, healthcare, or simply provide more breathing room in retirement.

This would leave most Australians well-placed for a comfortable retirement.

How much superannuation is needed?

If a superannuation portfolio generated a 3% dividend yield, it would need to be worth around $1.73 million to produce $52,000 per year in passive income.

That is a large amount of money, but it is worth noting that the required balance falls as the portfolio yield rises.

A 4% yield would require a balance of around $1.3 million. A 5% yield would require approximately $1.04 million. A 6% yield would need about $867,000, while a 7% yield would require roughly $743,000.

That shows why yield makes such a big difference.

The same $52,000 income target can require a very different super balance depending on the investments selected.

Should investors chase the highest yield?

A higher yield can make the numbers look more achievable, but it can also introduce more risk.

The highest-yielding ASX shares are not always the safest income options.

Sometimes a very high dividend yield appears because the share price has fallen sharply and the market expects the dividend to be cut. In other cases, the company may be under pressure from weaker earnings, rising debt, lower commodity prices, or a cyclical downturn.

A better approach is to look for income that can be sustained. That means focusing on companies with reliable cash flow, sensible payout ratios, strong balance sheets, and businesses that can continue operating through different economic conditions.

A portfolio built only around maximum yield can become fragile. But a portfolio built around quality income has a better chance of lasting.

What could a passive income portfolio include?

ASX shares can be useful inside superannuation because many pay dividends and some come with franking credits.

Large banks, infrastructure shares, property trusts, telecommunications companies, retailers, and listed investment companies can all play a role.

Examples could include income-focused blue chips such as Commonwealth Bank of Australia (ASX: CBA), Telstra Group Ltd (ASX: TLS), or Wesfarmers Ltd (ASX: WES).

Investors looking for property or infrastructure-style income might consider names such as Charter Hall Long WALE REIT (ASX: CLW), APA Group (ASX: APA), or Transurban Group (ASX: TCL).

Listed investment companies and dividend-focused ETFs can also help spread income across a wider range of holdings.

Foolish takeaway

A $52,000 annual passive income stream from superannuation is possible, but it generally requires a sizeable portfolio.

The rough balance needed could range from about $743,000 at a 7% yield to $1.73 million at a 3% yield.

Most investors may prefer to sit somewhere in the middle, balancing income with quality, diversification, and long-term capital preservation.

But it is always worth remembering that the goal is not just to reach $52,000 in one year. It is to build an income stream that can keep supporting retirement for many years to come.

The post How much do I need in my superannuation to get $52,000 per year in passive income? appeared first on The Motley Fool Australia.

More reading

• Which ASX 200 sectors paid the highest dividend yields in FY26?
• Wesfarmers shares are closing in on record highs. Buy, hold or sell?
• Dump ’em! Morgan Stanley slaps sell ratings on 5 ASX 200 shares
• 9 ASX 200 shares downgraded by analysts this week
• How to build $60,000 in annual passive income from ASX dividend shares

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Transurban Group and Wesfarmers. The Motley Fool Australia has positions in and has recommended Apa Group, Telstra Group, and Transurban Group. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

US stocks operate on a different fiscal year cycle from S&P/ASX 200 Index (ASX: XJO) shares.

However, as so many of us are invested in both markets, it’s relevant to compare their performance over a given period.

So, let’s canvas what happened in the Australian financial year (FY26) from 1 July 2025 to 30 June 2026.

Let’s compare…

S&P/ASX 200 Index (ASX: XJO) shares increased 2.77% and delivered total returns, including dividends, of 7% in FY26. 

The S&P/ASX All Ords Index (ASX: XAO) rose 2.43% and provided total returns of 5.69%, according to S&P Global data.

By comparison, the S&P 500 Index (SP: INX) rose by 20.86% and delivered total returns of 22.32%.

The Nasdaq Composite Index (NASDAQ: .IXIC) ascended 28.69% and gave a total return of 30.55%.

The Dow Jones Industrial Average (DJX: .DJI) rose 18.65% and delivered a total return of 20.65%.

Why did US stocks outperform ASX 200 shares?

Drew Meredith from Wattle Partners says it comes down to America’s leading position in the artificial intelligence (AI) revolution.

In an article in The Golden Times, Meredith explained:

The United States market is being driven by a small number of companies with outsized earnings power, almost all tied to artificial intelligence infrastructure.

Nvidia, Microsoft, Alphabet, Meta, and Amazon have delivered earnings growth that justifies, at least in part, the premium valuations US indices now carry.

Meanwhile, ASX 200 shares struggled to grow in FY26 amid resurgent inflation, three interest rate hikes in February, March, and May (reversing the impact of one cut in August), the energy crisis, and weak consumer confidence.

On top of that, fears of an AI bubble and a SaaSpocalypse weighed on our tech sector, which dove 37% in FY26.

ASX 200 healthcare shares also tumbled 37% amid many industry challenges, including a weaker US currency impacting global players.

Meredith says the Federal Budget’s CGT reform package, announced in May, has also weighed on financial shares and property, too.

Can the US markets keep delivering?

Shaun Manuell, Chief Investment Officer (CIO) at AustralianSuper, isn’t ready to call the top of the US stock market yet.

In the Weekend Australian, Manuell described US equities being in the “rational exuberance phase”.

He said:

The retail investor is back in the US, and I think there’s a lot of weight behind that.

When the US equity market gets going it’s a very, very powerful engine. So, I wouldn’t be calling the top of that just yet.

As for ASX 200 shares, Manuell is not optimistic for FY27.

It’ll be another challenging year; you’re going to have to be really careful in the sectors.

We know consumer sentiment’s down, house prices are down, and that leads through to the wealth effect as well.

Manuell said AusSuper is “slightly overweight” US stocks, and underweight ASX shares compared to global stocks.

He likes ASX 200 mining shares but is underweight bank stocks.

Should you buy US stocks?

Meredith warns against ‘recency bias’ and any temptation investors may feel to switch out of ASX 200 shares in order to buy US stocks.

Meredith explains:

When one market dramatically outperforms another for two or three years, investors feel they were wrong to be diversified. That feeling is not evidence. It is recency bias.

The periods of sharpest US outperformance relative to global peers have consistently been followed by periods of mean reversion.

This happened after the dot-com peak in 2000. It happened in the early years after the GFC when US banks were recovering and Australian miners were printing money.

It does not happen on a schedule you can predict, which is precisely why systematic diversification matters more than tactical shifts.

Manuell says his team is eyeing off a recent pullback in the Magnificent Seven US stocks as a potential buying opportunity.

He also said he is more comfortable investing in the “picks and shovels” of the AI revolution, commenting:

Everyone’s been playing the picks and shovels because they can see there’s money to be made but this is just making the infrastructure.

Once we’ve got the infrastructure, what’s going to happen? Nobody knows…

3-year snapshot of ASX 200 shares vs. US stocks

Total returns	FY24	FY25	FY26
ASX 200	11.44%	13.81%	7%
ASX All Ords	11.44%	13.23%	5.69%
S&P 500	25.02%	15.16%	22.32%

The post ASX 200 shares vs. US stocks in FY26 appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Friday
• Here are the top 10 ASX 200 shares today
• Is the ASX 200 heading for a third straight fall as oil prices jump?
• Steadfast Group extends exclusivity on $6.00 per share takeover offer
• Fletcher Building lifts FY26 profit guidance as quarterly volumes rise

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon, Meta Platforms, Microsoft, and Nvidia. The Motley Fool Australia has recommended Alphabet, Amazon, Meta Platforms, Microsoft, and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.